Promoting and facilitating strategies to improve cardiovascular health worldwide

Promoting and facilitating strategies to improve cardiovascular health worldwide

Promoting and facilitating strategies to improve cardiovascular health worldwide

Promoting and facilitating strategies to improve cardiovascular health worldwide

Upcoming Events

newsfeed

GLP-1 agonists semaglutide, liraglutide may help to treat alcohol use disorder

Posted on November 20, 2024

Patients with alcohol use disorder who used GLP-1 agonists to treat obesity or type 2 diabetes had a decreased risk for hospitalization... more

Greater cardiorespiratory fitness could reduce risk for dementia by 40%

Posted on November 20, 2024

High cardiorespiratory fitness corresponded with better cognitive function and a decreased risk for dementia, according to findings published in the British Journal... more

Potassium binder helps optimize spironolactone use in patients with HF, hyperkalemia risk

Posted on November 20, 2024

CHICAGO — A potassium binder helped patients with HF who have or are at high risk for hyperkalemia stay on spironolactone at... more

Telemedicine-supported low-carb diet linked to type 2 diabetes remission, weight loss

Posted on November 19, 2024

A telemedicine-based nutrition counselling program emphasizing a low-carbohydrate diet resulted in sustained diabetes remission over half a decade for some individuals with... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.

 

  •   Alberto Lorenzatti

    VP / President Elect

    Affiliations/Memberships Founder and Past President of the Argentine Lipids Society (2003-2005); Current Chair of the Americas Federation from the International Atherosclerosis Society (IAS). Research Interests Atherosclerosis Lipid Metabolism Inflammation and CHD more

  •   Georg Noll

    Treasurer

      Georg Noll is a specialist in General Internal Medicine and Cardiology at Heart Clinic Zurich. He was Associate Professor of Cardiology (more…) more

  •   Pablo Avanzas

    Secretary

    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more

  •   Sang Hong Baek

    President

    Professor Sang Hong Baek is Director of Heart Failure and Transplantation Programme and Preventive Cardiology at Seoul St. Mary's (more…) more